Your browser is no longer supported. Please, upgrade your browser.
Settings
DGX [NYSE]
Quest Diagnostics Incorporated
IndexS&P 500 P/E8.73 EPS (ttm)16.78 Insider Own0.40% Shs Outstand125.00M Perf Week2.80%
Market Cap17.89B Forward P/E17.72 EPS next Y8.27 Insider Trans-34.17% Shs Float113.07M Perf Month-4.58%
Income2.24B PEG- EPS next Q2.87 Inst Own97.30% Short Float3.92% Perf Quarter5.86%
Sales11.06B P/S1.62 EPS this Y70.70% Inst Trans-0.07% Short Ratio3.55 Perf Half Y10.75%
Book/sh47.19 P/B3.10 EPS next Y-30.66% ROA16.30% Target Price154.80 Perf Year15.95%
Cash/sh4.59 P/C31.94 EPS next 5Y-8.59% ROE34.70% 52W Range113.36 - 160.56 Perf YTD22.93%
Dividend2.48 P/FCF9.60 EPS past 5Y16.60% ROI13.80% 52W High-8.76% Beta1.02
Dividend %1.69% Quick Ratio1.30 Sales past 5Y4.70% Gross Margin41.70% 52W Low29.23% ATR2.93
Employees40000 Current Ratio1.40 Sales Q/Q39.60% Oper. Margin24.50% RSI (14)52.02 Volatility2.33% 1.96%
OptionableYes Debt/Eq0.68 EPS Q/Q265.50% Profit Margin20.20% Rel Volume1.00 Prev Close145.36
ShortableYes LT Debt/Eq0.68 EarningsOct 21 BMO Payout13.50% Avg Volume1.25M Price146.49
Recom2.10 SMA201.59% SMA50-1.92% SMA2008.90% Volume1,248,481 Change0.78%
May-04-21Upgrade UBS Neutral → Buy $135 → $158
Mar-12-21Downgrade Robert W. Baird Outperform → Neutral $137
Oct-21-20Upgrade Argus Hold → Buy
Jul-29-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $144
Jul-14-20Upgrade BofA Securities Neutral → Buy $142
Jun-09-20Upgrade Wells Fargo Underweight → Equal Weight $90 → $120
Jun-02-20Upgrade Deutsche Bank Hold → Buy $140
Apr-28-20Upgrade Morgan Stanley Equal-Weight → Overweight $139
Apr-27-20Upgrade Wolfe Research Underperform → Peer Perform
Apr-27-20Upgrade Citigroup Neutral → Buy $113 → $130
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $95
Jan-08-20Initiated Wells Fargo Underweight $100
Jan-07-20Downgrade Barclays Overweight → Equal Weight $106
Dec-19-19Upgrade BofA/Merrill Underperform → Neutral $94 → $110
Jul-15-19Downgrade Goldman Neutral → Sell $90 → $85
Apr-02-19Upgrade Jefferies Hold → Buy $93 → $107
Mar-18-19Resumed Credit Suisse Neutral $101 → $91
Jan-31-19Downgrade Argus Buy → Hold
Jan-17-19Initiated UBS Neutral $90
Jan-03-19Downgrade BofA/Merrill Neutral → Underperform
Oct-21-21 01:46PM  
01:30PM  
10:44AM  
08:55AM  
08:05AM  
07:07AM  
07:05AM  
06:53AM  
06:45AM  
Oct-20-21 10:20AM  
08:37AM  
Oct-18-21 01:22PM  
10:09AM  
07:01AM  
Oct-15-21 10:56AM  
09:10AM  
Oct-14-21 03:01PM  
08:30AM  
06:53AM  
Oct-13-21 04:16PM  
06:30AM  
Oct-12-21 08:45AM  
08:16AM  
06:45AM  
Oct-11-21 12:14PM  
10:52AM  
10:21AM  
Oct-08-21 11:50AM  
09:51AM  
Oct-07-21 08:26AM  
Oct-05-21 10:00AM  
08:30AM  
Oct-01-21 06:30AM  
Sep-29-21 12:55PM  
11:05AM  
09:50AM  
07:09AM  
06:40AM  
Sep-28-21 11:16AM  
07:03AM  
Sep-23-21 12:01PM  
Sep-22-21 10:49AM  
10:06AM  
Sep-20-21 08:24AM  
Sep-16-21 07:12AM  
Sep-14-21 09:58AM  
07:51AM  
Sep-10-21 07:59AM  
Sep-09-21 09:55AM  
07:17AM  
06:45AM  
Sep-02-21 09:00PM  
Sep-01-21 10:30AM  
Aug-31-21 11:19AM  
Aug-30-21 11:18AM  
Aug-25-21 09:16AM  
Aug-19-21 10:58AM  
Aug-18-21 02:19PM  
Aug-17-21 04:01PM  
06:45AM  
Aug-16-21 06:30PM  
Aug-12-21 11:37AM  
Aug-11-21 09:21AM  
09:03AM  
Aug-06-21 09:00AM  
Jul-30-21 06:55AM  
Jul-29-21 07:21AM  
Jul-24-21 04:40AM  
Jul-22-21 04:00PM  
11:32AM  
09:21AM  
08:05AM  
07:37AM  
07:01AM  
07:01AM  
06:45AM  
Jul-21-21 07:35AM  
Jul-20-21 08:30AM  
Jul-19-21 09:56AM  
Jul-15-21 03:01PM  
Jul-14-21 11:34AM  
Jul-12-21 10:11AM  
Jul-08-21 06:39AM  
Jul-06-21 09:31AM  
Jul-01-21 04:30AM  
Jun-28-21 08:51AM  
Jun-23-21 09:43AM  
09:34AM  
Jun-22-21 08:17AM  
06:44AM  
Jun-21-21 06:45AM  
Jun-18-21 06:20AM  
Jun-17-21 11:40AM  
Jun-02-21 09:14AM  
Jun-01-21 04:05PM  
May-28-21 09:00AM  
May-26-21 09:01AM  
08:07AM  
May-25-21 03:56PM  
09:21AM  
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 29Option Exercise95.809,493909,382289,727Jul 30 04:16 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 29Sale140.879,4931,337,251284,427Jul 30 04:16 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 28Option Exercise95.80139,75113,387,447424,178Jul 30 04:16 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 28Sale140.14139,75119,584,845284,427Jul 30 04:16 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 27Option Exercise95.8032,7883,140,926317,215Jul 28 04:21 PM
WILENSKY GAIL RDirectorJul 27Option Exercise59.3912,222725,92623,956Jul 28 04:18 PM
WILENSKY GAIL RDirectorJul 27Sale139.3012,2221,702,47017,845Jul 28 04:18 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 27Sale140.0132,7884,590,550284,427Jul 28 04:21 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 26Option Exercise95.805,813556,856290,240Jul 28 04:21 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentJul 26Sale140.035,813813,994284,427Jul 28 04:21 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.May 07Sale139.968,5361,194,72468,729May 11 04:27 PM
PREVOZNIK MICHAEL ESVP & General CounselMay 05Option Exercise71.1744,9393,198,30985,091May 07 04:32 PM
PREVOZNIK MICHAEL ESVP & General CounselMay 05Sale137.0044,9396,156,64340,152May 07 04:32 PM
PREVOZNIK MICHAEL ESVP & General CounselMar 10Sale120.475,574671,50040,152Mar 11 04:31 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 25Sale115.4980192,50740,152Mar 01 04:29 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 24Sale116.951,188138,93740,953Feb 25 04:39 PM
GUINAN MARKExecutive Vice President & CFODec 24Option Exercise66.5181,7565,437,592155,335Dec 28 04:27 PM
GUINAN MARKExecutive Vice President & CFODec 24Sale120.3781,7569,840,67373,579Dec 28 04:27 PM
WILENSKY GAIL RDirectorNov 24Option Exercise57.666,111352,39122,593Nov 27 04:38 PM
WILENSKY GAIL RDirectorNov 24Sale126.026,111770,12016,482Nov 27 04:38 PM
STANZIONE DANIELDirectorNov 23Sale126.3011,2231,417,45928,349Nov 24 04:31 PM